These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6557915)

  • 1. A team approach to... the obese type II diabetic.
    Diabetes Educ; 1983; 9(3):44-5. PubMed ID: 6557915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Care of the diabetic patient].
    Krüger E
    Klin Sygepleje; 1997 Feb; 11(1):29-33. PubMed ID: 9414498
    [No Abstract]   [Full Text] [Related]  

  • 3. A team approach to weight loss.
    Satterfield DW; Friesman J
    Diabetes Educ; 1985; 11(2):73-5. PubMed ID: 3852735
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of weight reduction on compensation in diabetic obese patients with non-insulin dependent diabetes mellitus].
    Szabó M
    Vnitr Lek; 1998 Mar; 44(3):145-50. PubMed ID: 9820092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetic outpatient clinic has nursing team].
    Sairaanhoitaja; 1974 Oct; 50(19):19-22. PubMed ID: 4499032
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.
    Shukla UA; Chi EM; Lehr KH
    Ann Pharmacother; 2004 Jan; 38(1):30-5. PubMed ID: 14742789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.
    Sivitz WI; Wayson SM; Bayless ML; Sinkey CA; Haynes WG
    J Diabetes Complications; 2007; 21(3):149-57. PubMed ID: 17493547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between plasma leptin and anthropometric and metabolic covariates in lean and obese diabetic and hyperlipidaemic Asian Northern Indian subjects.
    Misra A; Arora N; Mondal S; Pandey RM; Jailkhani B; Peshin S; Chaudhary D; Saluja T; Singh P; Chandna S; Luthra K; Vikram NK
    Diabetes Nutr Metab; 2001 Feb; 14(1):18-26. PubMed ID: 11345162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of beta 3-adrenergic receptor gene with obesity in patients with type 2 diabetes mellitus].
    Chen Y; Xu Y; Zhou L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):333-5. PubMed ID: 11769635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is new in the treatment of diabetes mellitus?].
    Gain T
    Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum resistin levels in Syrian obese patients with diabetes mellitus type II.
    Al-Sari IE; Al-Quobaili FA; Kabalan YM
    Saudi Med J; 2007 Dec; 28(12):1890-4. PubMed ID: 18060223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.
    Luzio SD; Dunseath G; Owens DR
    Horm Metab Res; 2002 May; 34(5):271-4. PubMed ID: 12063642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodontal status and cytoplasmic enzyme activities in gingival crevicular fluid of type 2 diabetic and/or obese patients with chronic periodontitis.
    Gursoy UK; Marakoglu I; Ersan S
    J Int Acad Periodontol; 2006 Jan; 8(1):2-5. PubMed ID: 16459882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reference value and cut-off value for diagnosis of insulin resistance in type 2 diabetes mellitus].
    Kuwana B; Urayama O; Kawai K
    Rinsho Byori; 2002 Apr; 50(4):398-403. PubMed ID: 12014020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.
    Daousi C; Casson IF; Gill GV; MacFarlane IA; Wilding JP; Pinkney JH
    Postgrad Med J; 2006 Apr; 82(966):280-4. PubMed ID: 16597817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obesity and diabetes in the aged--correlation and relation to some chronic diseases].
    Weber P; Dedek I; Kocourková B
    Z Gerontol; 1993; 26(4):280-4. PubMed ID: 8212799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.